BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19726785)

  • 1. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation.
    Wetter JA; Revankar C; Hanson BJ
    J Biomol Screen; 2009 Oct; 14(9):1134-41. PubMed ID: 19726785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
    van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
    J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays.
    Doucette C; Vedvik K; Koepnick E; Bergsma A; Thomson B; Turek-Etienne TC
    J Biomol Screen; 2009 Apr; 14(4):381-94. PubMed ID: 19403921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility.
    Hobson JP; Rosenfeldt HM; Barak LS; Olivera A; Poulton S; Caron MG; Milstien S; Spiegel S
    Science; 2001 Mar; 291(5509):1800-3. PubMed ID: 11230698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictability of peripheral lymphocyte reduction of novel S1P1 agonists by in vitro GPCR signaling profile.
    Xu H; McElvain M; Fiorino M; Henkle B; Sherman L; Xu Y; Tominey E; Kelley K; Adlam M; Bürli R; Siu J; Wong M; Cee VJ
    J Biomol Screen; 2013 Oct; 18(9):997-1007. PubMed ID: 23686102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface receptors in lysophospholipid signaling.
    Anliker B; Chun J
    Semin Cell Dev Biol; 2004 Oct; 15(5):457-65. PubMed ID: 15271291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of the pharmacology of Sphingosine-1-phosphate S1P3 receptor ligands using the DiscoveRx PathHunter™ and Ca2+ release functional assays.
    Riddy DM; Stamp C; Sykes DA; Charlton SJ; Dowling MR
    Br J Pharmacol; 2012 Oct; 167(4):868-80. PubMed ID: 22577868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay.
    Yin H; Chu A; Li W; Wang B; Shelton F; Otero F; Nguyen DG; Caldwell JS; Chen YA
    J Biol Chem; 2009 May; 284(18):12328-38. PubMed ID: 19286662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
    Laroche G; Giguère PM
    Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment.
    Hanson BJ; Wetter J; Bercher MR; Kopp L; Fuerstenau-Sharp M; Vedvik KL; Zielinski T; Doucette C; Whitney PJ; Revankar C
    J Biomol Screen; 2009 Aug; 14(7):798-810. PubMed ID: 19531663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the BRET 7TM receptor/beta-arrestin assay in drug discovery and screening.
    Heding A
    Expert Rev Mol Diagn; 2004 May; 4(3):403-11. PubMed ID: 15137906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization.
    Sykes DA; Riddy DM; Stamp C; Bradley ME; McGuiness N; Sattikar A; Guerini D; Rodrigues I; Glaenzel A; Dowling MR; Mullershausen F; Charlton SJ
    Br J Pharmacol; 2014 Nov; 171(21):4797-807. PubMed ID: 24641481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway.
    Yamazaki Y; Kon J; Sato K; Tomura H; Sato M; Yoneya T; Okazaki H; Okajima F; Ohta H
    Biochem Biophys Res Commun; 2000 Feb; 268(2):583-9. PubMed ID: 10679247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells.
    Waters CM; Connell MC; Pyne S; Pyne NJ
    Cell Signal; 2005 Feb; 17(2):263-77. PubMed ID: 15494217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological effects of lysophospholipids.
    Rivera R; Chun J
    Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
    Goetzl EJ; Kong Y; Mei B
    J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors.
    Verkaar F; van Rosmalen JW; Blomenröhr M; van Koppen CJ; Blankesteijn WM; Smits JF; Zaman GJ
    Biotechnol Annu Rev; 2008; 14():253-74. PubMed ID: 18606367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards selective lysophospholipid GPCR modulators.
    Archbold JK; Martin JL; Sweet MJ
    Trends Pharmacol Sci; 2014 May; 35(5):219-26. PubMed ID: 24746475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles for N-glycosylation in the dynamics of Edg-1/S1P1 in sphingosine 1-phosphate-stimulated cells.
    Kohno T; Igarashi Y
    Glycoconj J; 2004; 21(8-9):497-501. PubMed ID: 15750791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.